logo

Diseases and Drugs

Share

fda2021 dec29 As 2020 draws to a close, it's time to take a look back at some of the regulatory news that made headlines in December and look ahead at what's in store for January 2021. As for the novel drug approvals, 53 drugs secured FDA nod in 2020 compared to 48 in 2019. Let's take a look at the biotech companies whose drugs are at the FDA altar awaiting a decision in January 2021.

oxlumo nov37 As November comes to a close, it's time to take a look back at some of the top news stories of the month related to FDA approvals and look ahead at what's in store for December. A couple of firsts happened on the regulatory front in the month. Let's take a look at the biotech stocks that await a ruling from the FDA in December.

syringesvials nov25 Vaccination is an effective way to halt a pandemic. In the ongoing COVID-19 pandemic, the number of confirmed cases across the globe has crossed 60 million, with over 1.42 million fatalities, as of this writing. The U.S., which has reported 12.77 million cases and over 262,000 deaths, remains the worst-hit country.

vaccine nov16 An effective coronavirus vaccine is one good way to put an end to the pandemic. According to the World Health Organization, 48 vaccines targeting the SARS-CoV-2 virus are in clinical evaluation and 168 are in preclinical stage.

fdaapproved nov16 Four new drugs were approved by the FDA in the month of October. This compares with 11 drugs approved by the regulator last year.

fda oct23 On October 22, the FDA approved Gilead's (GILD) Veklury (remdesivir), the first drug for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization. Let's take a look at the companies that await a ruling from the FDA in November.

drug sept25 As of this writing, the FDA has approved 40 novel drugs so far this year compared to just 27 during the same period (Jan-Sep) last year. Now, let's take a look at the biotech stocks facing FDA decision in October.

russia aug25 So far this year, 36 novel drugs have passed muster with the FDA compared to 26 during the same period (Jan- Aug) in 2019. Let's take a look at the companies that await a ruling from the FDA in September.

inqovi july24 As another month comes to a close, it's time to take a look back at some of the top news stories of July related to FDA approvals and look ahead at what's coming next over the horizon.

fdadecision april28 25jun20 The first half of 2020 looks set to end on an encouraging note for new drug approvals despite the ongoing coronavirus pandemic. Let's take a look at the biotech stocks facing FDA decision in July.

astrazeneca june12 When will a safe and effective vaccine for COVID-19 be ready? Vaccine makers are racing against time to develop a vaccine to fight the novel coronavirus. There are more than 130 candidate vaccines in development against SARS-COV-2, the pathogen that causes COVID-19, of which 10 have moved into clinical trials.

solenopws june09 Although there are FDA approved therapies for the treatment of growth failure in children with PWS, say, Pfizer's (PFE) recombinant human growth hormone Genotropin (somatropin) and Sandoz/Novartis' Omnitrope, a biosimilar for Genotropin, there is no approved therapy yet to treat hyperphagia or excessive eating, the cardinal symptom of PWS.

fda1 may22 The FDA has been focusing mainly on COVID-19-related review since March. But that said, the regulatory decision on drugs proposed for rare tumors and life-threatening diseases has not been deferred. Now, let's take a look at the biotech stocks awaiting a regulatory decision in the month of June.

lab april30 The ongoing COVID-19 pandemic has sickened over 3.25 million people and has killed 233,014 people, according to data from Johns Hopkins University.

fda2 042420 So far this year, 16 novel drugs have received FDA approval compared to 9 which were greenlighted during the same period last year. Now, let's take a look at the biotech stocks that are awaiting a regulatory decision in May 2020.

Follow RTT